Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-08

Clinical Trial Update: Azelaic Acid 20% vs Hydroquinone 4% in Epidermal Melasma [NA]

View source ↗

Summary

A completed clinical trial comparing azelaic acid 20% with hydroquinone 4% for epidermal melasma (facial melasma). The update notes completion of the study but …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azelaic acid 20% (azelaic acid)
  • Hydroquinone 4% (hydroquinone)

Snippet

Sponsor: Gujranwala medical college District Headquarters Hospital, Gujranwala | Conditions: Melasma, Melasma (Facial Melasma) | NA | Status: COMPLETED